{"slideshow_credits": null, "snippet": "A lawsuit claims that a giant French pharmaceutical favored its own multiple sclerosis treatment to avoid making a huge payout.", "abstract": "Gretchen Morgenson Fair Game column examines lawsuit claiming French pharmaceutical firm Sanofi favored its own multiple sclerosis drug over that of Genzyme, which it bought in 2011, to dodge $3.8 billion in payments to Genzyme shareholders.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Gretchen", "role": "reported", "lastname": "MORGENSON", "rank": 1, "organization": ""}], "original": "By GRETCHEN MORGENSON"}, "web_url": "http://www.nytimes.com/2015/11/15/business/after-merger-two-competing-drugs-and-billion-dollar-questions.html", "lead_paragraph": "A lawsuit claims that a giant French pharmaceutical favored its own multiple sclerosis treatment to avoid making a huge payout.", "headline": {"print_headline": "One Merger, Two Drugs, Millions Lost", "main": "After Merger, Two Competing Drugs and Billion-Dollar Questions", "content_kicker": "Fair Game", "kicker": "Fair Game"}, "_id": "5645eddd38f0d8244c637543", "word_count": "1020", "multimedia": [{"height": 126, "url": "images/2015/11/15/business/gret-web1/gret-web1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/11/15/business/gret-web1/gret-web1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 424, "url": "images/2015/11/15/business/gret-web1/gret-web1-articleLarge.jpg", "legacy": {"xlarge": "images/2015/11/15/business/gret-web1/gret-web1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "424"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/11/15/business/gret-web1/gret-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/11/15/business/gret-web1/gret-web1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-11-15T00:00:00Z", "source": "The New York Times", "news_desk": "SundayBusiness", "keywords": [{"name": "organizations", "value": "Genzyme Corp", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Sanofi SA", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Suits and Litigation (Civil)", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "5"}, {"name": "subject", "value": "Multiple Sclerosis", "is_major": "Y", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "News"}